Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the wide adoption of next-generation sequencing. However, many cases remain undiagnosed even after exome or genome analysis, because the methods used missed the molecular cause in a known gene, or a novel...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!